Medical Marijuana, Inc. Portfolio Company AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for IBS … – SYS


NEW YORK, NY –(Marketwired – November 01, 2016) – Medical Marijuana, Inc. (OTC: MJNA) today announced that its portfolio company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) has begun pharmacokinetic/pharmacodynamics (PK/PD) studies with its CanChew Plus® Gum, the first CBD hemp oil chewing gum, to ascertain the potential for a reduction of irritable bowel syndrome (IBS) symptoms in patients.

Wageningen

... read more at: http://news.sys-con.com/node/3944624

by